BioDue S.p.A.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
BioDue S.p.A. - overview
Established
1986
Location
Florence, -, Italy
Primary Industry
Pharmaceuticals
About
Based in Italy, BioDue S. p. A. specializes in the development and manufacturing of medical devices, food supplements, and cosmetics, utilizing advanced technologies to meet diverse healthcare needs.
BioDue S. p. A. is a health product manufacturer founded in 1986, headquartered in Florence, Italy.
The company has undergone a recent change in ownership, with The Riverside Company acquiring BioDue in November 2022 from Armonia SGR and Fidim S. r. l. The founders and management team have committed to reinvest in the company.
BioDue has participated in 2 deals, with the latest funding round being a PIPE of EUR 35. 20 mn, raising a total of EUR 35. 20 mn to date. BioDue S.
p. A. specializes in the manufacturing of a diverse range of health-oriented products, focusing on medical devices, food supplements, and cosmetics. The company employs advanced production technologies to create nearly all pharmaceutical forms, with offerings such as the innovative "Caps-in-Caps" technology that protects active ingredients and ensures controlled release.
BioDue serves a variety of clients, including pharmaceutical companies and wellness brands, primarily in the European market, while also exploring expansions into other regions. In the most recent year, BioDue reported a revenue of EUR 65. 01 mn and an EBITDA of EUR 9. 67 mn.
Revenue generation is achieved through business-to-business partnerships with pharmaceutical and healthcare firms, involving contract manufacturing and long-term agreements to produce branded products. Looking ahead, BioDue S. p. A.
aims to expand its service offerings and market presence, supported by its recent acquisition. The company plans to launch new products and enter additional markets, focusing on specific geographic regions to be determined. The EUR 35. 20 mn raised in the latest PIPE funding will facilitate these growth initiatives, enabling organic expansion and potential acquisitions to enhance its capabilities and reach.
Current Investors
Armonia, Fidim
Primary Industry
Pharmaceuticals
Sub Industries
Beauty & Hygiene, Health Foods & Nutritional Supplements, Medical Equipment Distributors, Medical Supplies, Pharmaceutical Research & Development
Website
www.biodue.com/
Verticals
Manufacturing
Company Stage
Mature - Growth Capital
Total Amount Raised
Subscriber access only
BioDue S.p.A. - timeline of key events
BioDue S.p.A. - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Add-on, Corporate Carve Out | Completed | VLG's CDMO Business | - | ||||||||
| Add-on, Corporate Carve Out | Completed | BMG Pharma s.p.A.'s Healthea Licensing S.r.l. | - | ||||||||
| Secondary Buyout | Completed | BioDue S.p.A. | - | ||||||||
| Add-on | Completed | Farcoderma S.r.l. | - | ||||||||
| PIPE | Completed | BioDue S.p.A. | - |
Displaying 1 - 5 of 5
BioDue S.p.A. - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.